Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization

Table 1 P53 protein expression of different types of HCC

Groups	Histological types
	Trabecular	Pseudoglandar	Solid	Clear cell	Poorly differentiated	Sclerosis
Non-TACE	63.66 ± 19.96	72.29 ± 12.47	70.83 ± 24.45	68.27 ± 19.22	74.79 ± 16.18	72.11 ± 0.00
TACE	56.90 ± 17.12	72.35 ± 13.70	74.93 ± 8.76	62.15 ± 11.78	73.66 ± 8.54
P	> 0.05	> 0.05	> 0.05	> 0.05	> 0.05

Table 2 Expressions of proteins in different grades of HCC

Treat groups	I	II	III	IV
Non-TACE	60.99 ± 30.58	67.22 ± 15.53	72.98 ± 20.60	93.47 ± 0.00
TACE	32.59 ± 11.68	60.02 ± 14.67	74.69 ± 8.65	82.64 ± 1.11
P	> 0.05	< 0.05	> 0.05	> 0.05

Table 3 Correlation p53 expression with Ki-67, PCNA, Bax, Bcl-2 and AI

			Ki-67	PCNA	bcl-2	bax	bcl-2/bax	AI
Non-TCAE group	P53	PC	0.454a	0.331a	-0.141	0.054	-0.375a	-0.198
TACE group	P53	PC	0.553a	0.577a	0.007	-0.142	0.001	-0.459a

^aCorrelation is significant at the 0.05 level (2-tailed), PC: Pearson correlation.